Status:
RECRUITING
Basal Plasma Lithium Levels and Suicidal Events
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Major Depressive Disorder
Suicidal Behavior
Eligibility:
All Genders
18+ years
Brief Summary
Suicidal behavior is a major public health issue and there are currently no specific treatments for it. However, lithium, the reference treatment for bipolar disorder, have been shown to be effective...
Detailed Description
This study aims to assess the rate of depressed patients (unipolar or bipolar) with basal plasma lithium levels above 0.1 µeq/L. It also aims to : * compare basal plasma lithium levels according to ...
Eligibility Criteria
Inclusion
- 18 years old or over
- Current major depressive episode according to the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) criteria
- No lithium-based treatment over the last 12 months
- For suicide attempters/ideations only : suicidal event over the last 12 months
- For affective controls only : no suicidal event over the last 12 months
Exclusion
- Lifetime diagnosis of schizoaffective disorder, schizophrenia or psychosis
- Pregnancy or breastfeeding
- Deprivation of freedom (by judicial or administrative decision)
- Legal protection measure (guardianship or curators)
- Inability to understand experimental procedures
- No affiliation to the French National Social Security System
- No consent to participate in the study
Key Trial Info
Start Date :
December 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 9 2027
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT05409794
Start Date
December 9 2022
End Date
January 9 2027
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Montpellier
Montpellier, France